Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis
ABSTRACT Mitochondrial dysfunction and antioxidant deficiency are key contributors to the pathogenesis of Alzheimer's disease (AD). Trimethyltin (TMT) induces selective hippocampal damage associated with redox disequilibrium, neuroinflammatory responses, mitochondrial dysfunction, and impaired energy homeostasis, leading to cognitive decline. The present study evaluated whether simvastatin as a lipid‐lowering and protective medicine could mitigate TMT‐induced behavioral abnormalities by improving hippocampal antioxidant status, mitochondrial integrity, and energy homeostasis. Rats were assigned to control, control + simvastatin (30 mg/kg), TMT, TMT + simvastatin (10 mg/kg), and TMT + simvastatin (30 mg/kg) groups. TMT was injected IP (once, 8 mg/kg) to instigate neurotoxicity. Following three weeks of treatment, locomotor activity and conditioned learning and memory deficits were analyzed using open‐field and passive avoidance tests, respectively. Besides, hippocampal levels or activity of nitrite, glutathione (GSH), glutathione peroxidase (GPx), myeloperoxidase (MPO), and β‐site APP‐cleaving enzyme 1 (BACE1), mitochondrial membrane potential (MMP), and AMP‐activated protein kinase (AMPK) were measured. Simvastatin treatment (30 mg/kg) was associated with higher latency in the passive avoidance test and longer rearing in the open field test in TMT‐intoxicated rats. Additionally, simvastatin improved hippocampal GSH, GPx, MMP, and AMPK and mitigated MPO activity relative to the TMT group but did not significantly affect nitrite or BACE‐1 activity. Collectively, simvastatin mitigated TMT‐induced neurobehavioral impairment, partly through restoration of antioxidants and mitochondrial health in association with AMPK.
Authors
- Mohsen Khalili (ORCID: https://orcid.org/0000-0002-7154-676X)
- Adel Salari Esker (ORCID: https://orcid.org/0000-0002-8075-3170)
- Mahdieh Taheri (ORCID: https://orcid.org/0000-0002-7898-9969)
- Mehrdad Roghani (ORCID: https://orcid.org/0000-0002-9209-8484)
Institutions
- Shahed University (IR)
- Kharazmi University (IR)
Publication Details
- Journal
- Pharmacology Research & Perspectives
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1002/prp2.70352
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00